We are live on ! Find out more
ISEE

IVERIC bio, Inc. Common Stock
ISEE

Delisted

ISEE was delisted on the 10th of July, 2023.

Back to rankings

98 hedge funds and large institutions have $1.18B invested in IVERIC bio, Inc. Common Stock in 2014 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 38 increasing their positions, 15 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 13

153% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 15

54% more capital invested

Capital invested by funds: $768M → $1.18B (+$412M)

50% more funds holding in top 10

Funds holding in top 10: 4 → 6 (+2)

34% more funds holding

Funds holding: 73 → 98 (+25)

58% less call options, than puts

Call options by funds: $2.34M | Put options by funds: $5.54M

Holders
98
Holders Change
+25
Holders Change %
+34.25%
% of All Funds
2.82%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.17%
New
39
Increased
38
Reduced
15
Closed
13
Calls
$2.34M
Puts
$5.54M
Net Calls
-$3.2M
Net Calls Change
+$3.12M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$68.3M
2
JCG
JHL Capital Group
Illinois
+$55.8M
3
State Street
State Street
Massachusetts
+$13.6M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$12.5M
5
Morgan Stanley
Morgan Stanley
New York
+$9.24M

Top Sellers

1
CV
Clarus Ventures
Massachusetts
-$55M
2
RCM
RA Capital Management
Massachusetts
-$44.4M
3
CCM
Consonance Capital Management
New York
-$11.1M
4
ICAP
Independence Capital Asset Partners
Colorado
-$8.9M
5
BA
BlackRock Advisors
Delaware
-$1.77M
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
76
Deutsche Bank
Germany
$262K +$66.1K +1,801 +41%
Jane Street
77
Jane Street
New York
$249K +$216K +5,879 New
BA
78
BlackRock Advisors
Delaware
$248K -$1.77M -48,314 -89%
ARC
79
Absolute Return Capital
Massachusetts
$193K -$836K -22,786 -83%
MCM
80
Manchester Capital Management
Vermont
$162K – – –
Bank of America
81
Bank of America
North Carolina
$122K +$86.3K +2,351 +453%
Canada Life
82
Canada Life
Manitoba, Canada
$93K +$80.7K +2,200 New
PCM
83
Prelude Capital Management
New York
$79K +$68.2K +1,860 New
FMT
84
First Mercantile Trust
Tennessee
$63K +$54.3K +1,480 New
VFA
85
Virtus Fund Advisers
Connecticut
$50K +$43.4K +1,184 New
CWM
86
Cranbrook Wealth Management
Michigan
$42K – – –
BG
87
BlackRock Group
United Kingdom
$36K +$18.2K +495 +137%
PNC Financial Services Group
88
PNC Financial Services Group
Pennsylvania
$26K +$8.95K +244 +73%
Teacher Retirement System of Texas
89
Teacher Retirement System of Texas
Texas
$23K +$19.7K +538 New
U
90
UBS
Switzerland
$17K +$1.54K +42 +12%
BlackRock
91
BlackRock
New York
$14K -$141K -3,851 -92%
First Manhattan
92
First Manhattan
New York
$14K +$12.8K +350 New
Bank of Montreal
93
Bank of Montreal
Ontario, Canada
$10K +$8.44K +230 New
TRCT
94
Tower Research Capital (TRC)
New York
$9K -$19.9K -542 -71%
Citigroup
95
Citigroup
New York
$5K -$49K -1,336 -92%
GSC
96
Ground Swell Capital
South Carolina
$5K +$4.62K +126 New
PTC
97
Private Trust Company
Ohio
$1K – – –
BNP Paribas Financial Markets
98
BNP Paribas Financial Markets
France
$85 -$367 -10 -83%
CCM
99
Consonance Capital Management
New York
– -$11.1M -311,287 Closed
ICAP
100
Independence Capital Asset Partners
Colorado
– -$8.9M -249,590 Closed
1 2 3
4
5

ISEE Hedge Fund Activity: Q2 2014 in Review

98 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q2 2014, worth a combined $1.18B — up 54% from $768M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new ISEE positions and 13 closed out — a net gain of 26 holders — while 38 added to existing stakes and 15 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $68.3M. The largest seller was Clarus Ventures, cutting an estimated $55M.

  • 98 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q2 2014, up from 73 in Q1 2014.
  • Funds reported $1.18B of IVERIC bio, Inc. Common Stock stock for Q2 2014, up 54% quarter-over-quarter.
  • 39 funds opened new IVERIC bio, Inc. Common Stock positions in Q2 2014 and 13 closed out, a net change of +26 holders.
  • The largest IVERIC bio, Inc. Common Stock buyer in Q2 2014 was Fidelity Investments, an estimated $68.3M added.
  • The largest IVERIC bio, Inc. Common Stock seller in Q2 2014 was Clarus Ventures, an estimated $55M sold.

Based on aggregated 13F filings for Q2 2014.